Virtu Financial LLC - INTEC PHARMA LTD JERUSALEM ownership

INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 29 filers reported holding INTEC PHARMA LTD JERUSALEM in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q4 2019$57,000
-40.6%
114,318
-13.2%
0.01%
-14.3%
Q3 2019$96,000
+9.1%
131,642
+669.7%
0.01%
+40.0%
Q4 2017$88,00017,1020.01%
Other shareholders
INTEC PHARMA LTD JERUSALEM shareholders Q4 2019
NameSharesValueWeighting ↓
Prosight Management, LP 815,789$3,541,0001.78%
MEITAV INVESTMENT HOUSE LTD 2,460,136$10,651,0000.71%
DAFNA Capital Management LLC 415,989$1,805,0000.68%
KNOTT DAVID M 259,377$1,126,0000.48%
SECTORAL ASSET MANAGEMENT INC 879,000$3,815,0000.46%
SPHERA FUNDS MANAGEMENT LTD. 620,000$2,691,0000.37%
ESSEX INVESTMENT MANAGEMENT CO LLC 283,434$1,230,0000.17%
Harel Insurance Investments & Financial Services Ltd. 624,809$2,711,0000.14%
Avoro Capital Advisors LLC 820,000$3,559,0000.12%
MENTA CAPITAL LLC 52,792$229,0000.10%
View complete list of INTEC PHARMA LTD JERUSALEM shareholders